Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study
Abstract Although the efficacy of propranolol for the treatment of infantile hemangiomas (IHs) has been well documented, there is a paucity of clinical data regarding the safety and tolerance of propranolol in neonates. A prospective study of 51 patients less than 30 days of age with severe IH was c...
Main Authors: | Yi Ji, Siyuan Chen, Bo Xiang, Yang Yang, Liqing Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-01321-2 |
Similar Items
-
Neonatal Abdominal Hemangiomatosis: Propranolol beyond Infantile Hemangioma
by: Siu Ying Angel Nip, et al.
Published: (2016-01-01) -
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011-08-01) -
Propranolol in the Treatment of Infantile Hemangiomas
by: Tan X, et al.
Published: (2021-09-01) -
Treatment of infantile hemangioma with propranolol
by: Gian Maria Pacifici -
Use of propranolol in infantile hemangioma
by: Manish K Shah, et al.
Published: (2017-01-01)